Skip to content

The Effect of Family Integrated Care on Melatonin Level in Very Low Birth Weight Infants

The Effect of Family Integrated Care on Melatonin Level in Very Low Birth Weight Infants in Neonatal Intensive Care Unit: A Multicenter Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05483231
Enrollment
64
Registered
2022-08-02
Start date
2023-12-01
Completion date
2024-04-30
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Very Low Birth Weight Infant

Keywords

Family integrated care, Melatonin

Brief summary

This study will explore the effect of Family integrated care (FICare) on the level of melatonin and other clinical outcomes in very low birth weight infants (VLBWIs) by integrating families into the neonatal intensive care unit (NICU) care team and participating in the daily care of VLBWIs, as well as the influence of FIcare on parents' outcomes.

Detailed description

This study is a multicenter randomized controlled trial which mainly explores the effect of Family integrated care (FICare) on melatonin levels in very low birth weight infants (VLBWIs) in neonatal intensive care unit (NICU). The intervention group will use a FICare intervention program, mainly for families who have been fully trained by the NICU professional team and need to stay in the NICU to accompany and care for the VLBWIs for not less than 6 hours a day for at least 3 weeks. All non-medical care measures and developmental supportive care will be provided by parents as much as possible. The control group received routine nursing interventions in which all non-medical interventions are led by NICU staff and without parental involvement. The level of melatonin, clinical and parental outcomes in VLBWIs are compared between the intervention group and the control group to evaluate the effect of FICare intervention program.

Interventions

BEHAVIORALFamily integrated care intervention group

If the very low birth weight infants' vital signs are stable at 32 weeks of corrected gestational age, parents who have been fully trained will provide all non-medical care measures and developmental care for the VLBWIs in the NICU for not less than 6 hours per day for at least 3 weeks, and other medical practice and care measures will be the same as the routine group.

Routine practice and in-hospital education will be given to the very low birth weight infants and parents. All care measures will be led by the nursing staff, without the participation of parents.

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Hours to 24 Hours
Healthy volunteers
No

Inclusion criteria

* Birth weight \< 1500g; * Gestational age \< 32w; * Admit within 24 hours of birth; * The parents are conscious and able to cooperate, have certain learning and reading comprehension skills, and are capable of caring for their babies. They are committed to receiving training and caring for their babies for not less than 6 hours a day for at least 21 days; * Voluntarily participate in this study and sign informed consent.

Exclusion criteria

* Newborns who require palliative care or surgical intervention; * OI (oxygenation index) \<300 ; * Newborns with severe congenital malformations;

Design outcomes

Primary

MeasureTime frameDescription
Changes on the level of Melatonin in very low birth weight infantsFrom baseline to day 21 after the implementation of Family integrated care interventionAt 32 weeks of corrected gestational age (baseline) and day 21 after the implementation of FICare intervention, melatonin will be quantitatively measured by high performance liquid chromatography-mass spectrometry (HPLC-MS) with saliva samples collected by a specially-assigned person.

Secondary

MeasureTime frameDescription
Changes in maternal milk volumeFrom baseline to day 21 after the implementation of Family integrated care interventionAt 32 weeks of corrected gestational age (baseline) and day 21 after the implementation of FICare intervention, maternal milk volume will be collected from lactation diary records issued before the intervention.
Rate of weight gainFrom baseline to day 21 after the implementation of Family integrated care interventionWeight is measured by a parent or nurse. Rate of weight gain = ( Weight measured at day 21 after the intervention - weight measured at 32 weeks of corrected gestational age)/total number of intervention days.
Breast feeding rateAt the day 21 after the implementation of Family integrated care interventionData will be acquired at the day 21 after the implementation of FICare intervention by a specially-assigned person. Breastfeeding rate = number of VLBWI fed from mother's milk/total number of VLBWI enrolled in each group \*100%.
Length of hospitalizationThrough study completion, about an average of 21 daysLength of hospitalization refers to the total number of days from 32 weeks of corrected gestational age (baseline) to the day of discharge. Data will be obtained from the case system.
Growth rate of head circumferenceFrom baseline to day 21 after the implementation of Family integrated care interventionHead circumference is measured by a parent or nurse. Growth rate of head circumference = ( head circumference measured at day 21 after the intervention - head circumference measured at 32 weeks of corrected gestational age)/total number of intervention days.
Incidence of complications related to preterm birthThrough study completion, about an average of 21 daysComplications related to preterm birth include neonatal sepsis, bronchopulmonary dysplasia (BPD), intraventicular hemorrhage (IVH), periventricular leukinomalacia (PVL), and retinopathy of prematurity (ROP). These complications are diagnosed by a neonatologist. If any of these conditions occurred during the intervention, complications related to preterm birth would be considered. Data will be obtained from the case system or data collection form.

Countries

China

Contacts

Primary ContactYi Zhang, Master
20211170025@fudan.edu.cn+8618071608186
Backup ContactXiaojing Hu, PhD
humama2015@126.com+8618017590869

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026